Pulse Biosciences Income from Continuous Operations 2016-2025 | PLSE
Pulse Biosciences income from continuous operations from 2016 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
| Pulse Biosciences Annual Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024 | $-54 |
| 2023 | $-42 |
| 2022 | $-59 |
| 2021 | $-64 |
| 2020 | $-50 |
| 2019 | $-47 |
| 2018 | $-38 |
| 2017 | $-26 |
| 2016 | $-10 |
| 2015 | $-3 |
| Pulse Biosciences Quarterly Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2025-03-31 | $-17 |
| 2024-12-31 | $-19 |
| 2024-09-30 | $-13 |
| 2024-06-30 | $-11 |
| 2024-03-31 | $-10 |
| 2023-12-31 | $-12 |
| 2023-09-30 | $-11 |
| 2023-06-30 | $-10 |
| 2023-03-31 | $-10 |
| 2022-12-31 | $-9 |
| 2022-09-30 | $-18 |
| 2022-06-30 | $-14 |
| 2022-03-31 | $-17 |
| 2021-12-31 | $-15 |
| 2021-09-30 | $-14 |
| 2021-06-30 | $-15 |
| 2021-03-31 | $-19 |
| 2020-12-31 | $-14 |
| 2020-09-30 | $-13 |
| 2020-06-30 | $-11 |
| 2020-03-31 | $-12 |
| 2019-12-31 | $-14 |
| 2019-09-30 | $-12 |
| 2019-06-30 | $-11 |
| 2019-03-31 | $-10 |
| 2018-12-31 | $-9 |
| 2018-09-30 | $-11 |
| 2018-06-30 | $-9 |
| 2018-03-31 | $-9 |
| 2017-12-31 | $-9 |
| 2017-09-30 | $-7 |
| 2017-06-30 | $-6 |
| 2017-03-31 | $-3 |
| 2016-12-31 | $-3 |
| 2016-09-30 | $-3 |
| 2016-06-30 | $-2 |
| 2016-03-31 | $-2 |
| 2015-12-31 | $-1 |
| 2015-09-30 | $-1 |
| 2015-06-30 | $-1 |
| 2015-03-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.045B | $0.001B |
| Pulse Biosciences, Inc. is a medical device company. It is engaged in developing a novel and proprietary tissue treatment platform using Nano-Pulse Electro-Signaling. NPES provide effective local tumor control and to initiate an adaptive immune response. The company deploy NPES platform applications which include human oncology, dermatology, aesthetics and other minimally invasive applications. Pulse Biosciences, Inc. is based in Burlingame, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $188.994B | 82.78 |
| Thermo Fisher Scientific (TMO) | United States | $160.877B | 19.46 |
| Edwards Lifesciences (EW) | United States | $44.810B | 29.38 |
| IDEXX Laboratories (IDXX) | United States | $43.334B | 49.80 |
| Alcon (ALC) | Switzerland | $42.937B | 29.02 |
| DexCom (DXCM) | United States | $32.843B | 50.76 |
| IQVIA Holdings (IQV) | United States | $28.453B | 15.94 |
| Mettler-Toledo (MTD) | United States | $25.075B | 29.82 |
| STERIS (STE) | Ireland | $22.878B | 25.20 |
| Waters (WAT) | United States | $20.696B | 29.20 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.375B | 0.00 |
| Hologic (HOLX) | United States | $14.463B | 15.71 |
| Sysmex ADR (SSMXY) | Japan | $10.481B | 29.73 |
| Penumbra (PEN) | United States | $9.596B | 75.32 |
| Masimo (MASI) | United States | $8.802B | 32.47 |
| Globus Medical (GMED) | United States | $7.662B | 18.26 |
| Glaukos (GKOS) | United States | $5.853B | 0.00 |
| Teleflex (TFX) | United States | $5.289B | 8.73 |
| TransMedics (TMDX) | United States | $4.219B | 91.71 |
| Integer Holdings (ITGR) | United States | $4.123B | 21.60 |
| PROCEPT BioRobotics (PRCT) | United States | $3.204B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.544B | 15.15 |
| Veracyte (VCYT) | United States | $2.082B | 29.21 |
| Nihon Kohden (NHNKY) | Japan | $1.949B | 22.35 |
| Elekta AB (EKTAY) | Sweden | $1.931B | 17.36 |
| Alphatec Holdings (ATEC) | United States | $1.696B | 0.00 |
| Artivion (AORT) | United States | $1.306B | 122.32 |
| Tandem Diabetes Care (TNDM) | United States | $1.107B | 0.00 |
| OPKO Health (OPK) | United States | $1.079B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.010B | 5.37 |
| SiBone (SIBN) | United States | $0.774B | 0.00 |
| IRadimed (IRMD) | United States | $0.754B | 38.27 |
| Beta Bionics (BBNX) | United States | $0.579B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.571B | 12.38 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.570B | 8.87 |
| OrthoPediatrics (KIDS) | United States | $0.527B | 0.00 |
| AxoGen (AXGN) | United States | $0.523B | 0.00 |
| RxSight (RXST) | United States | $0.520B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.502B | 11.77 |
| Pacific Biosciences Of California (PACB) | United States | $0.450B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.443B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.430B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.387B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.373B | 0.00 |
| NeuroPace (NPCE) | United States | $0.340B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.329B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.274B | 0.00 |
| 908 Devices (MASS) | United States | $0.244B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.232B | 14.06 |
| Biosig Technologies (BSGM) | United States | $0.229B | 0.00 |
| Neuronetics (STIM) | United States | $0.226B | 0.00 |
| Inogen (INGN) | United States | $0.195B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.183B | 0.00 |
| CVRx (CVRX) | United States | $0.176B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| LENSAR (LNSR) | United States | $0.155B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.153B | 0.00 |
| Accuray (ARAY) | United States | $0.142B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.126B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.118B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.115B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.109B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.090B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.076B | 46.10 |
| Spectral AI (MDAI) | United States | $0.072B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.069B | 0.00 |
| InspireMD (NSPR) | United States | $0.069B | 0.00 |
| Hyperfine (HYPR) | United States | $0.061B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.060B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.057B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.053B | 21.44 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.027B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.025B | 0.00 | |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.019B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.72 |